老年病人耐碳青霉烯类肠杆菌医院感染流行病学及危险因素研究进展

doi:10.3969/j.issn.1003-9198.2023.01.020

实用老年医学 ›› 2023, Vol. 37 ›› Issue (1): 79-82.doi: 10.3969/j.issn.1003-9198.2023.01.020

老年病人耐碳青霉烯类肠杆菌医院感染流行病学及危险因素研究进展

于楠, 崔檬, 王佳贺

110004 辽宁省沈阳市,中国医科大学附属盛京医院全科医学科(于楠,王佳贺);宁养病房(崔檬)

收稿日期:2022-02-14 出版日期:2023-01-20 发布日期:2023-01-18
通讯作者: 王佳贺,Emai:wangjhcmusj@163.com
基金资助:
国家重点研发计划(2018YFC2002104,2018YFC2002100);辽宁省重点研发指导计划(2019JH8/10300021)

Received:2022-02-14 Online:2023-01-20 Published:2023-01-18

摘要/Abstract

中图分类号:

R 515

于楠, 崔檬, 王佳贺. 老年病人耐碳青霉烯类肠杆菌医院感染流行病学及危险因素研究进展[J]. 实用老年医学, 2023, 37(1): 79-82.

[1] 吴鸿滨.肠杆菌科细菌碳青霉烯类抗生素耐药治疗的研究进展[J].现代诊断与治疗,2021,32(8):1203-1205.
[2] 杨雪,刘琳,张湘燕.耐碳青霉烯类肺炎克雷伯杆菌的耐药机制及治疗策略研究进展[J].医学研究生学报,2018,31(4):430-434.
[3] LOGAN L K, WEINSTEIN R A.The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace[J].J Infect Dis, 2017,215(suppl 1):S28-S36.
[4] 冯丽娜,李从荣.肺炎克雷伯菌碳青霉烯酶的研究进展[J].医学综述,2017,23(2):318-322,326.
[5] LIAO W J, LIU Y, ZHANG W.Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years[J].J Glob Antimicrob Resist,2020,23:174-180.
[6] SU S, ZHANG J, ZHAO Y, et al.Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics[J].BMC Infect Dis,2020,20(1):472.
[7] 韩仁如,胡付品.耐碳青霉烯类肠杆菌科细菌中OXA-48家族碳青霉烯酶分子流行病学研究进展[J].中国感染与化疗杂志,2019,19(6):687-690.
[8] DAGHER C, SALLOUM T, ALOUSI S, et al.Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon[J].PLoS One,2018,13(9):e0203323.
[9] GUPTA V, YE G, OLESKY M, et al.Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017[J].BMC Infect Dis,2019,19(1):742.
[10] CHAMIEH A, EL-HAJJ G, ZMERLI O, et al.Carbapenem resistant organisms: a 9-year surveillance and trends at Saint George University Medical Center[J].J Infect Public Health,2020,13(12):2101-2106.
[11] ROUX J, NEKKAB N, COLOMB-COTINAT M, et al.Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20[J].J Antimicrob Chemother, 2021,76(1):226-232.
[12] LI Y, SUN Q L, SHEN Y,et al.Rapid increase in prevalence of carbapenem-resistant Enterobacteriaceae(CRE) and emergence of colistin resistance gene mcr-1 in CRE in a hospital in Henan, China[J]. J Clin Microbiol,2018, 56(4):e01932-17.
[13] LIU X J, LUAN Y, LI Y, et al.Trends in antimicrobial resistance against Enterobacteriaceae strains isolated from blood: a 10-year epidemiological study in Mainland China(2004-2014)[J]. Chin Med J: Engl, 2017,130(17):2050-2055.
[14] 全国细菌耐药监测网.全国细菌耐药监测网 2014-2019 年老年患者常见临床分离细菌耐药性监测报告[J].中国感染控制杂志,2021,20(2):112-123.
[15] KIM S H, KIM G R, KIM E Y, et al.Carbapenemase-producing Eenterobacterales from hospital environment and their relation to those from patient specimens[J].J Infect Public Health,2022,15(2):241-244.
[16] BOUGANIM R, DYKMAN L, FAKEH O, et al.The clinical and molecular epidemiology of noncarbapenemase-producing carbapenem-resistant Enterobacteriaceae: a case-case-control matched analysis[J].Open Forum Infect Dis, 2020,7(8):ofaa299.
[17] SAEED N K, ALKHAWAJA S, AZAM N F A E M, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in a Tertiary Care Center in the Kingdom of Bahrain[J].J Lab Physicians, 2019, 11(2):111-117.
[18] HU Y, LIU C, SHEN Z, et al.Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008-2018[J].Emerg Microbes Infect, 2020, 9(1):1771-1779.
[19] 刘凤鸣,易文枫,黄贵,等.ICU老年患者耐碳青霉烯类肠杆菌科细菌感染的影响因素[J].中国老年学杂志,2021,41(8):1673-1675.
[20] JOUHAR L, JAAFAR R F, NASREDDINE R, et al.Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon[J].Int Wound J, 2020,17(6):1764-1773.
[21] 唐洪影. 临床感染患者分离耐碳青霉烯肺炎克雷伯菌临床特征及分子流行病学研究[D].天津:天津医科大学,2020.
[22] 卢智奇,王淑颖.恶性肿瘤患者耐碳青霉烯类肺炎克雷伯菌血流感染研究进展[J].中国感染与化疗杂志,2021,21(3):358-361.
[23] TRAN D M, LARSSON M, OLSON L, et al.High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: risk factors and burden of disease[J].J Infect, 2019,79(2):115-122.
[24] 陈婷,朱芸.耐碳青霉烯类肠杆菌的临床分布及危险因素分析[J].实用医药杂志,2019,36(11):1029-1031.
[25] SHEU C C, CHANG Y T, LIN S Y, et al. Infections caused by Carbapenem Resistant Enterobacteriaceae: an update on therapeutic options[J]. Front Microbiol, 2019,10:80.
[26] 孙红娟,吕庆排,黄敏,等.某院2010-2019年常见肠杆菌目细菌临床分布及耐药性变迁[J].中国感染控制杂志,2021,20(6):524-531.
[27] 李小四,范陈良,冯燕,等.临床分离碳青霉烯类耐药肠杆菌科分布及其酶的表型分析[J].中国消毒学杂志,2021,38(5):342-344.
[28] DURANTE-MANGONI E, ANDINI R, ZAMPINO R. Management of carbapenem-resistant Enterobacteriaceae infections[J].Clin Microbiol Infect,2019,25(8):943-950.

老年病人耐碳青霉烯类肠杆菌医院感染流行病学及危险因素研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

Metrics

推荐阅读 10